Two-Stage Surgery in Patients with Diffuse Glioma—Indications, Implications and Outcome (2026) Jeising S, Reinken J, Rapp M, Sabel M, Staub-Bartelt F Journal article An Algorithmic Approach for Quantitative Determination of Microsatellite Status in NGS-Based Cancer Diagnostics (2026) Männlein J, Sterlacci W Journal article Composition of Immune Cells in Sporadic Vestibular Schwannomas with Different Tumor Volumes (2026) Becker AL, Klause CH, Staege MS, Willscher E, Scheffler J, Schildhauer P, Ostalecki C, et al. Journal article COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma (2026) Weichenthal M, Debus D, Zimmer L, Wasielewski Iv, Meier F, Tüting T, Heppt M, et al. Journal article The Prognostic Role of Para-Aortic Lymph Node Metastasis in Patients with Resected Pancreatic Adenocarcinoma (2025) Brunner M, Kitzke L, Mittelstädt A, Merkel S, Weber G, Grützmann R, Krautz C Journal article Exploring Endovascular Photo-Activated Ablation (EPA) for Downstaging Locally Advanced Pancreatic Cancer: A Proof-of-Concept Study in the Normal Porcine Model (2025) García Vázquez A, Verde JM, Wanert F, Spiridon IA, Schmid A, Saeidi T, Swanstrom LL, et al. Journal article Correction: CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (Cancers, (2022), 14, 2, (326), 10.3390/cancers14020326) (2025) Lan B, Zeng S, Zhang S, Ren X, Xing Y, Kutschick I, Pfeffer S, et al. Journal article, Erratum First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms (2025) Thomas S, Wermke M, Vučinić V, Wagner-Drouet E, Mackensen A, Zeiser R, Bug G, et al. Journal article The Effect of Lurbinectedin as a Monotherapy and in Combination with Ionizing Radiation on Sarcoma Cell Lines (2025) Alsheimer H, Schiller P, Semrau S, Grabenbauer F, Fietkau R, Distel L, Hildebrand L Journal article Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors (2025) Arnold L, Morak M, Kramer N, Berking C, Schefzyk M, Hassel JC, Ziemer M, et al. Journal article